Friday, October 3, 2014
RTA 408 Capsules in Patients With Friedreich's Ataxia (MOXIe)
RTA 408 Capsules in Patients With Friedreich's Ataxia (MOXIe). A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe). ClinicalTrials.gov Identifier: NCT02255435
Subscribe to:
Posts (Atom)
